12 Health Care Stocks Moving In Monday's Pre-Market Session

BenzingaMar 24 08:10 ET

Allarity Therapeutics Launches Comprehensive Effort to Combat Potential Illegal Naked Short Selling of Its Shares

GlobeNewswireMar 24 08:00 ET

Allarity Therapeutics Presents Phase 2 Clinical Data From Ongoing Trial In Advanced Ovarian Cancer Patients At The 2025 Annual Meeting For The Society Of Gynecologic Oncology

BenzingaMar 17 08:03 ET

Express News | Allarity Therapeutics: Consented, Without Admitting or Denying SEC's Findings, to Entry of Administrative Cease-and-Desist Order

ReutersMar 13 08:30 ET

Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination With Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration

GlobeNewswireMar 6 08:00 ET

Allarity Therapeutics Announces Board Authorization of $5 Million Share Repurchase Program

GlobeNewswireMar 3 08:00 ET